Abstract | BACKGROUND: AIM: To compare VBL and CI in the treatment of EV in patients with advanced liver disease. PATIENTS AND METHODS: Thirty-eight patients with medium or large EV and Child-Pugh index of at least eight were randomized into two groups: VBL (n=20) and CI (n=18). The patients were followed-up for at least 6 months after the end of treatment. Main outcomes were eradication, bleeding, mortality, complication, and recurrence rates. RESULTS: Variceal eradication rates were similar in the VBL and CI groups (90 vs. 72%, P=0.39). Mean number of sessions until eradication was 3.17 and 3, respectively. Bleeding episodes until eradication were equally observed in both groups (P=0.17). Mortality (55 vs. 56%, P=0.52) and major complication rates (5 and 17%, P=0.32) were similar. Chest pain with dysphagia was more frequent in the CI group (55.6 vs. 10%, P=0.004). A higher risk of variceal recurrence was observed in the CI group (33 vs. 57%, P=0.04). CONCLUSION: No significant differences between the VBL and CI groups were observed in the treatment of EV in patients with advanced liver disease regarding mortality, variceal eradication, and major complications rates. However, minor complications and variceal recurrence were significantly more common in the CI group. In addition, there was a clear trend toward more bleeding episodes in patients included in the CI group.
|
Authors | Marcus Melo Martins Santos, Luciano Henrique Lenz Tolentino, Rodrigo Azevedo Rodrigues, Frank Shigueo Nakao, Maria Rachel da Silveira Rohr, Gustavo Andrade de Paulo, Mario Kondo, Angelo Paulo Ferrari, Ermelindo Della Libera |
Journal | European journal of gastroenterology & hepatology
(Eur J Gastroenterol Hepatol)
Vol. 23
Issue 1
Pg. 60-5
(Jan 2011)
ISSN: 1473-5687 [Electronic] England |
PMID | 21084988
(Publication Type: Journal Article, Randomized Controlled Trial)
|
Chemical References |
|
Topics |
- Adult
- Cyanoacrylates
(adverse effects, therapeutic use)
- Endoscopy
(methods)
- Esophageal and Gastric Varices
(etiology, surgery)
- Female
- Gastrointestinal Hemorrhage
(therapy)
- Humans
- Injections
(adverse effects)
- Ligation
(adverse effects)
- Liver Diseases
(complications)
- Male
- Middle Aged
- Recurrence
- Treatment Outcome
|